Encompass Health Co. (NYSE:EHC) Shares Sold by Wedge Capital Management L L P NC

Wedge Capital Management L L P NC lessened its position in shares of Encompass Health Co. (NYSE:EHC) by 7.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 194,913 shares of the company’s stock after selling 15,775 shares during the period. Wedge Capital Management L L P NC’s holdings in Encompass Health were worth $13,005,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of EHC. McGlone Suttner Wealth Management Inc. purchased a new position in shares of Encompass Health in the 4th quarter valued at $30,000. C M Bidwell & Associates Ltd. acquired a new position in Encompass Health during the 3rd quarter worth approximately $35,000. Harvest Fund Management Co. Ltd acquired a new stake in Encompass Health during the 3rd quarter valued at $109,000. Acadian Asset Management LLC purchased a new position in Encompass Health in the 3rd quarter valued at about $111,000. Finally, EverSource Wealth Advisors LLC boosted its holdings in Encompass Health by 14.7% in the third quarter. EverSource Wealth Advisors LLC now owns 2,713 shares of the company’s stock valued at $182,000 after purchasing an additional 347 shares during the last quarter. 97.25% of the stock is owned by institutional investors and hedge funds.

Encompass Health Trading Up 1.4 %

Shares of NYSE:EHC traded up $1.10 during mid-day trading on Tuesday, hitting $81.43. The stock had a trading volume of 64,290 shares, compared to its average volume of 646,375. Encompass Health Co. has a 12-month low of $57.55 and a 12-month high of $83.73. The company has a debt-to-equity ratio of 1.19, a quick ratio of 1.28 and a current ratio of 1.28. The company has a market cap of $8.15 billion, a PE ratio of 23.14, a P/E/G ratio of 1.47 and a beta of 0.94. The company’s 50 day moving average is $77.52 and its 200-day moving average is $70.47.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Wednesday, February 7th. The company reported $0.95 earnings per share for the quarter, topping analysts’ consensus estimates of $0.83 by $0.12. Encompass Health had a return on equity of 17.69% and a net margin of 7.33%. The company had revenue of $1.25 billion during the quarter, compared to analysts’ expectations of $1.24 billion. On average, sell-side analysts predict that Encompass Health Co. will post 3.96 EPS for the current year.

Encompass Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Monday, April 1st were issued a $0.15 dividend. The ex-dividend date was Thursday, March 28th. This represents a $0.60 annualized dividend and a yield of 0.74%. Encompass Health’s dividend payout ratio (DPR) is 17.29%.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the stock. Mizuho increased their price target on shares of Encompass Health from $77.00 to $82.00 and gave the stock a “buy” rating in a research report on Friday, February 9th. Barclays raised their price target on Encompass Health from $95.00 to $101.00 and gave the stock an “overweight” rating in a report on Thursday, March 28th. Royal Bank of Canada reiterated an “outperform” rating and issued a $83.00 target price on shares of Encompass Health in a research note on Friday, February 9th. Truist Financial lifted their price objective on shares of Encompass Health from $82.00 to $86.00 and gave the company a “buy” rating in a research report on Friday, February 9th. Finally, Stephens reiterated an “overweight” rating and set a $85.00 price objective on shares of Encompass Health in a research report on Tuesday, January 16th. Eight research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus price target of $83.22.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.